Mississippi Gov. Tate Reeves (R) signed into law today a bill to bar drugmaker 340B contract pharmacy restrictions and certain [...] …
Articles by : William Newton, Associate Editor/Senior Writer
After Virginia Gov. Glenn Youngkin (R) amended a bill to delay legislation prohibiting certain drugmaker 340B contract pharmacy restrictions in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Despite its overwhelming support from the state legislature, Virginia Gov. Glenn Youngkin (R) late yesterday amended a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
South Carolina last week became the twenty-third state to introduce a bill this legislative session to bar drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Maryland and Kansas legislatures have each cleared bills that would prohibit drug manufacturer 340B contract pharmacy restrictions in their [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Mississippi state senate yesterday overwhelmingly cleared for the governor’s consideration a bill to prohibit drugmaker 340B contract pharmacy restrictions, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...] …
